| Similar Articles |
|---|
 |
Bio-IT World
October 2006
Kevin Davies |
Search and Deploy The Biogen Idec library has been transformed into a den of literature informatics and text mining, with librarians there not content just to handle complicated queries, but anxious to seek out and tackle problems researchers didn't know could be asked.   |
The Motley Fool
March 31, 2010
Brian Orelli |
When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies. |
Information Today
December 10, 2013 |
EBSCO Discovery Service Integrates Full-Text Patents EBSCO Information Services added content from the United States Patent and Trademark Office to EBSCO Discovery Service. |
Information Today
June 10, 2002
Nancy Lambert |
Patent Express: The End of an Era Patent information is a growth industry these days, and customers are demanding inexpensive access to international as well as U.S. patent documents. |
Bio-IT World
December 15, 2003
Kline & Greenhalgh |
When Patents Persist What if that patent you're paying royalties on suddenly gets extended? Have you negotiated the best licensing deal possible? |
Military & Aerospace Electronics
November 2005 |
Sikorsky Designs Helicopters with SGI Servers Engineers will use the SGI computers to analyze digital prototypes in computer-generated wind tunnels and battle scenarios. Sikorsky deployed the SGI solutions to support computer-aided engineering design and analyses of current and future aircraft. |
The Motley Fool
June 3, 2010
Brian Orelli |
When All Else Fails, Sue Your Competitors Biogen thinks its patent covers its competitors' drugs in addition to Avonex and has filed a lawsuit demanding royalties from its competitors. |
Information Today
June 11, 2015 |
CCC Debuts Text Mining Solution Copyright Clearance Center launched RightFind XML for Mining, a text mining solution that helps commercial life science researchers. |
IndustryWeek
August 1, 2006 |
Patents: Eleven Issues To Consider... How patent savvy are you? |
Information Today
September 17, 2007
Paula J. Hane |
LexisNexis Adds TotalPatent to Its Suite of Solutions Against the backdrop of new technology patent infringement claims and Congress voting on changes to the U.S. patent law, LexisNexis introduced a new tool for patent professionals -- patent attorneys, information professionals, researchers, and engineers. |
Bio-IT World
September 2006
John A. Wass |
Integrating Knowledge The results of new mathematical routines have the potential to save pharmaceuticals millions of dollars in drug development. And yet the flow of successful drugs is dwindling. The problem goes beyond bureaucracy and lies in the complexity of the problem. |
Bio-IT World
November 2005 |
Bridges and Boundaries in Drug Discovery Research Good communication, blurring cultural boundaries, and strong project governance may be as, if not more, important as sweeping technology solutions when it comes to converging discovery and IT and expediting drug development. |
Bio-IT World
November 12, 2002
Beth E. Arnold |
Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield. |
Inc.
July 24, 2002
Jennifer A. Redmond |
Strategic Patenting What to consider when you're filing a patent and strategic decisions you'll need to make. |
Salon.com
April 24, 2000
Mark Compton |
Lean, green gene-counting machine Incyte CEO Roy Whitfield gives biotech investors and patent critics a few lessons on genomic research. |
InternetNews
March 17, 2010 |
SGI Joins Xeon Lovefest With Origin Revival SGI, the vendor that grew out of Rackable Systems' acquisition of Silicon Graphics, has hopped on the Xeon bandwagon with a new line of x86 servers based on Intel's new Westmere technology. |
InternetNews
June 4, 2004
Susan Kuchinskas |
Microsoft Double-click Patent Sows FUD Will you pay Redmond every time you click-click? |
Bio-IT World
November 19, 2004
Lentini & Bent |
Intellectual Property: Patents and Genomic Medicine Patents, so critical to encouraging investment in developing new technologies, threaten to become a legal and economic minefield that could prevent effective commercial exploitation of genomics. |
